Of these, only vascular endothelial growth factor (VEGF) and CXCR4, showed additive responses to TGF-β and hypoxia, suggesting limited crosstalk between TGF-β and hypoxia signaling pathways in breast cancer cells. This evidence concerns the gene CXCR4 and breast carcinoma.